Following fields are empty!

1
Search
2
Select
3
Submit
169
Journals
Go to Previous Page
Page 5 of 9
Go to Next Page

Request Journal

Please fill in the form to request a new journal to be added. We will review your request and add it to the Journal Guide as soon as possible.

*

Journal of China Pharmaceutical University

ISSN: 1000-5048
Publisher: China Pharmaceutical University
Visit Publisher homepage
Pharmaceutical SciencePharmacology
Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Go to Journal

Journal of Chinese Pharmaceutical Sciences

ISSN: 1003-1057eISSN: 1003-1057
DOAJ Logo
Publisher: Peking University
Visit journal homepageView author guidelinesView aims and scope
Pharmaceutical Science
Loading data ...
Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Go to Journal

Journal of Controlled Release

ISSN: 0168-3659eISSN: 1873-4995
SIGAPS Level A
Publisher: Elsevier
Visit Publisher homepageVisit journal homepage
Chemistry(all)Pharmaceutical Science

The Journal of Controlled Release publishes high-quality research from and for pharmaceutical and biomaterials scientists in academia and industry on drug delivery, including drug biological properties of drugs, drug release mechanisms, drug delivery routes, drug delivery vehicles, bioactive polymers and hydrogels for drug delivery, delivery approaches, tissue engineering, and molecular imaging. Each issue has gene delivery and nanomedicine sections along with the cover story.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Read more
Loading data ...
Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Institutional Agreement

Tous les auteurs correspondants des Hospices Civils de Lyon ont la possibilité de publier leurs articles de recherches en Open Access dans cette revue. Pour bénéficier de cette prise en charge, déclarez les "Hospices Civils de Lyon" dans votre affiliation principale et utilisez votre adresse mail "@chu-lyon.fr" lors de la soumission de votre article.

ATTENTION:

  • Si l'éditeur vous demande de sélectionner la licence applicable, privilégiez la licence CC-BY à toutes autres.
  • Pour les revues non éligibles, dont The Lancet et les revues Cell Press, ou en cas d’épuisement du stock de droits, la publication en accès ouvert immédiat devient payante mais de manière optionnelle ; le tarif bénéficie dans ce cas d’une remise de 10%.
  • Les articles publiés en accès ouvert immédiat au titre de l’accord peuvent être déposés dans leur version finale éditeur dans une archive ouverte, par exemple dans HAL-HCL.
  • Dans le cas des articles sous abonnement, il est permis par la Loi République numérique de déposer dans une archive ouverte le manuscrit auteur accepté d’un article et de le diffuser avec un embargo de 6 mois (sciences dures) ou 12 mois (SHS).

Si vous rencontrez des difficultés ou si vous avez des questions, contactez la Documentation Centrale sur sa.documentationcentrale@chu-lyon.fr ou au 04-72-11-29-99 (31-29-99)